Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
about
Nanoparticles: health effects - pros and consRecent advances in dendrimer-based nanovectors for tumor-targeted drug and gene deliveryA single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas.Examination of structure-activity relationship of viologen-based dendrimers as CXCR4 antagonists and gene carriers.Image-guided tumor-selective radioiodine therapy of liver cancer after systemic nonviral delivery of the sodium iodide symporter gene.A p53-derived apoptotic peptide derepresses p73 to cause tumor regression in vivo.Polymeric drugs: Advances in the development of pharmacologically active polymers.Systemic TNFα gene therapy synergizes with liposomal doxorubicine in the treatment of metastatic cancer.Gene therapy in head and neck cancer: a review.Tumour and dendrimers: a review on drug delivery aspects.Micro/nanostructured polymeric systems for biomedical and pharmaceutical applications.Dendrimers for enhanced drug solubilization.Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates.Dendrimeric nanoarchitectures mediated transdermal and oral delivery of bioactivesCationic nanosystems for the delivery of small interfering ribonucleic acid therapeutics: a focus on toxicogenomics.Nonviral vectors for the delivery of small interfering RNAs to the CNS.Nanomaterials: applications in cancer imaging and therapy.Systemic tumor-specific gene delivery.Poly(amidoamine) dendrimer complexes as a platform for gene delivery.Applications of dendrimers for brain delivery and cancer therapy.Advances in the application of nanotechnology in the diagnosis and treatment of gastrointestinal tumors.Polyethylenimine-mediated in vivo gene transfer of a transmembrane superantigen fusion construct inhibits B16 murine melanoma growth.Non-viral cancer gene therapy: beyond delivery.Tumour gene expression from C12 spermine amphiphile gene delivery systems.Hydration forces as a tool for the optimization of core–shell nanoparticle vectors for cancer gene therapy
P2860
Q23918086-6A36475B-E718-4794-92A5-841045D01074Q28085438-98E23A8D-B4B7-4FBB-AB56-F1B50D0EDFAFQ35130646-B2999944-286D-4750-8D43-E6430C3F2FC9Q35167546-634E283B-D4C8-4B9A-98C4-98698195451FQ35612571-E4FDC8FC-FC34-4AD6-B492-26793CAF569CQ35664079-9E5503E7-3EF6-4E57-8FDE-62E83DF9D7EDQ36307604-C57685C2-3394-4B34-96DC-5748265EF4EFQ36673686-D3CA705E-D320-49EF-B769-ACF7C1BF7C61Q37023446-C306A43D-CA69-484B-B725-2B6835272195Q37171165-7BC76EE2-1EFA-4932-97B6-22144D11E5DFQ37176404-B3DBD1E3-43CE-482B-BE65-E4234B922274Q37279284-37FDBB0D-593F-432E-8609-4FEAA6C60261Q37394856-A17EFB6B-232E-4FC0-90BC-37CB161F1664Q37472758-C32E4506-433C-4AA3-ACB4-0B6A5B57E6FBQ37798545-63693745-9F6E-4591-B4F4-366ADF51D910Q37805489-C04E9FE6-FF5A-442D-AC21-AE5FFD30ED39Q37857064-D32B1304-A24E-482A-A7EA-5FBFAC53B204Q38137609-4FC5069E-50BE-4478-BF52-815D43556155Q38156233-F810BAFB-C45D-4993-858B-E4BE5F7D6DC0Q38270096-18222E00-F1CF-45EA-8CBF-67015CE4A826Q38387165-BB08A270-9BFC-4B81-B56D-5C8C9FEF0910Q39962730-03C3579D-B49F-4D47-8FCB-B2554D8ABAC1Q44242183-DA2F3B9F-FBEF-42E3-AAA4-6D8707373A74Q45888469-CE02CF6E-18B1-4D0B-BA1D-8093A8854A8FQ57610433-A103B0D3-81F6-4316-B8A9-BFAE4DB38ED0
P2860
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Synthetic anticancer gene medi ...... or to cure established tumors.
@en
type
label
Synthetic anticancer gene medi ...... or to cure established tumors.
@en
prefLabel
Synthetic anticancer gene medi ...... or to cure established tumors.
@en
P50
P1433
P1476
Synthetic anticancer gene medi ...... tor to cure established tumors
@en
P2093
Irina Proutski
P304
P356
10.1158/0008-5472.CAN-04-4402
P407
P577
2005-09-01T00:00:00Z